FOXP3 and neoplasm: In parallel, we used multispectral immunofluorescence to confirm the localization of the CD8+, CD4+, FOXP3+, CD31+, and F4/80+ populations within the tumor 15 days after Delta-24-ACT treatment (Figure 5F and Supplemental Figure 5D).